Exhibit 99.1 CareDx Announces Third Quarter 2025 Financial Results Total Revenue of $100 Million Increased 21$372 Million to $376 Million BRISBANE, Calif., November 4, 2025, CareDx, Inc. (Nasdaq: CDNA) — The Transplant Company — a leading precision medicine company focused on the discovery, development and commercialization of clinically differentiated, high-value healthcare ...